<div id="readability-page-1"><div><p>Health care stocks followed the main indexes in a post-holiday decline, before bouncing back to close slightly higher, among a lack of market-moving news and data points.</p><p>    Arcadia Biosciences declined after the termination of a merger agreement with Roosevelt Resources that was announced just over a year ago. The company will resume its evaluation of strategic alternatives. </p><p>    Moderna, a major stock in the sector, was a top loser in the S&amp;P 500, although no particular piece of news seemed to be the culprit. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-26-25 1751ET</p></div></div>

MRNA

<p>Health care stocks initially declined post-holiday but recovered to close slightly higher. Arcadia Biosciences fell after ending a merger with Roosevelt Resources, while Moderna was a top loser in the S&P 500 without specific news causing the drop.</p>

Health Care Stocks Recover In Late Trade -- Health Care Roundup